Overview: Japanese Encephalitis IgM TestIntroduction: The Japanese Encephalitis IgM Test detects JEV IgM antibodies to diagnose recent encephalitis, causing fever or confusion. Aligned with 2023 WHO guidelines, it uses immunoassay for high specificity, supporting neurological screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected recent Japanese encephalitis.
Other Names: JEV IgM Assay, Recent Encephalitis Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: JEV IgM testing began in the 1980s with viral encephalitis research. Immunoassay-based methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects JEV IgM antibodies to diagnose recent encephalitis, guides treatment, and evaluates patients with fever or confusion.
Test Parameters: 1. JEV IgM Antibodies
Pretest Condition: No fasting required. Collect serum, CSF, or saliva. Report history of fever, confusion, or neurological symptoms.
Specimen: Serum (SST, 2-5 mL), CSF (sterile container, 1-2 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, confusion, seizures, or travel history to JEV-endemic areas. Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, encephalitis implications, and risks of CSF or blood collection.
Procedural Considerations: Uses immunoassay to detect JEV IgM in serum, CSF, or saliva. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for recent encephalitis diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Early infection may yield false negatives.
Clinical Significance: Positive JEV IgM confirms recent Japanese encephalitis, guiding supportive care. Negative results may require PCR or further testing.
Specialist Consultation: Consult a neurologist or infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: JEV PCR, brain MRI, or EEG to confirm encephalitis diagnosis.
Test Limitations: Cross-reactivity with other flaviviruses may occur; clinical correlation is needed. Early infection may yield false negatives.
References: WHO Encephalitis Guidelines, 2023; Journal of Clinical Virology, Solomon T, 2022.
